P&G Hygiene's sales stayed flat and its profit fell 6.7%
Procter & Gamble Hygiene and Health Care, which sells Whisper and Vicks in India, reported sales of about Rs 1,145 crore for the September quarter, down 0.4% from a year earlier.
Net profit fell 6.7% to Rs 195.84 crore. Expenses rose 2.5% over the same period.
Flat sales with rising costs is the whole story. There is no volume growth to absorb the input bill, so the increase lands directly on the profit line.
Two of the company's categories are among the least discretionary things an Indian household buys. When a portfolio that defensive stops growing in value terms, the likely explanation is competitive rather than macro — a cheaper regional or private-label pack taking units at the bottom of the range.
The read is that P&G has chosen to protect price over volume this quarter. That holds a brand's position on the shelf and holds its margin percentage, but it hands the extra units to whoever is willing to sell cheaper. Which of those costs more depends entirely on whether those shoppers come back.